Activation of beta3-AR with mirabegron in hypertrophic cardiomyopathy: the BETA3LVH trial.

28 August 2022 (16:45 - 17:00)
Organised by:
Congress Presentation Part of: Beta3 adrenergic agonists in the clinic: the end of the beginning Pharmacology and Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by